New flu pill for kids shows promise in early trial
NCT ID NCT06656026
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tested a new flu medicine called ZSP1273 in 72 children aged 2 to 17 with influenza A. The goal was to see how safe it is, how the body processes it, and whether it helps reduce flu symptoms. The trial took place in China and has already been completed.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- ZSP1273 granules
- What this could lead to
- If successful, this could lead to a new treatment option for children with influenza A, potentially shortening illness duration and reducing symptoms.
- What could go wrong
- This is an early-phase trial with only 72 participants, so results may not apply broadly. The drug may not prove more effective than existing flu treatments, and side effects are still being evaluated.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INFLUENZA A are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The First Affiliated Hospital Of Guangzhou Medical University
Guangzhou, Guangdong, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New rapid test could spot COVID and flu in minutes
- New rapid test could spot flu and RSV in minutes at your local clinic
- New swab test aims to spot COVID, flu, and RSV in minutes
- New device aims to detect flu, RSV, and COVID-19 in one quick test
- Rapid COVID and flu tests put to the test in real clinics
- New At-Home test could detect flu and COVID in minutes